Dezamigren 12.5 mg 2 is a targeted medication for the acute treatment of migraine attacks, with or without aura. Each tablet contains zolmitriptan, a selective serotonin receptor agonist (triptan), known for its fast and effective action against moderate to severe migraine symptoms.
Why Choose Dezamigren 12.5 mg?
Dezamigren is designed for individuals suffering from disabling migraines who require fast, reliable relief. Its active substance, zolmitriptan, works by narrowing blood vessels in the brain and reducing the release of inflammatory substances that trigger migraine pain, nausea, and light sensitivity.
Main Benefits
- Effectively treats migraine attacks with or without aura
- Rapid onset of action — relief often within 30–60 minutes
- Reduces headache pain, nausea, and sensitivity to light and sound
- Convenient tablet form for on-the-go use
How to Use
The recommended dose is one 12.5 mg tablet at the onset of migraine symptoms. If the migraine returns, a second dose may be taken after at least 2 hours. Do not exceed 25 mg within 24 hours. Always use Dezamigren exactly as prescribed by your healthcare provider.
Who Is It For?
Dezamigren is suitable for adults with diagnosed migraine attacks who need fast-acting, effective relief. It is not intended for the prevention of migraines. Not recommended for individuals with cardiovascular disease, uncontrolled hypertension, or a history of stroke. Always consult your doctor before use.
High Standards by Aflofarm
Manufactured by Aflofarm, a reputable pharmaceutical company recognized for its innovation and product quality, Dezamigren offers clinically tested migraine relief in a practical 2-tablet package — ideal for emergency use or occasional attacks.
For full product details, visit the manufacturer’s official website: www.aflofarm.com.pl
